{
  "scenario_id": "healthcare_genomics_research_investment_2025",
  "context": "Biopharmaceutical company evaluating major investment in genomics research for personalized medicine platform",
  "stakeholders": {
    "requester": "Chief Scientific Officer",
    "approvers": ["CEO", "CFO", "Board of Directors"],
    "influencers": ["Head of R&D", "Chief Medical Officer", "VP Business Development", "Key Opinion Leaders", "Regulatory Experts"]
  },
  "request": {
    "amount": "$200 million",
    "purpose": "Build comprehensive genomics research platform for drug discovery and personalized medicine development",
    "urgency": "medium",
    "justification": "Genomics represents the future of medicine with potential to revolutionize drug development and patient outcomes"
  },
  "decision_process": [
    {
      "stage": "scientific_feasibility",
      "duration": "8 weeks",
      "activities": ["Technology landscape assessment", "Scientific advisory board consultations", "IP portfolio evaluation"],
      "outcome": "Strong scientific foundation with clear path to clinical applications"
    },
    {
      "stage": "market_analysis",
      "duration": "6 weeks",
      "activities": ["Market size projections", "Competitive landscape analysis", "Reimbursement pathway assessment"],
      "outcome": "Attractive market opportunity with $50B+ addressable market by 2030"
    },
    {
      "stage": "financial_modeling",
      "duration": "4 weeks",
      "activities": ["NPV analysis", "Sensitivity testing", "Funding strategy development"],
      "outcome": "Positive NPV with attractive risk-adjusted returns"
    },
    {
      "stage": "strategic_alignment",
      "duration": "3 weeks",
      "activities": ["Portfolio fit assessment", "Synergy evaluation", "Strategic priority alignment"],
      "outcome": "Excellent strategic fit with existing capabilities and pipeline"
    },
    {
      "stage": "risk_assessment",
      "duration": "2 weeks",
      "activities": ["Technical risk evaluation", "Regulatory risk analysis", "Execution risk assessment"],
      "outcome": "Manageable risk profile with clear mitigation strategies"
    }
  ],
  "business_impact": {
    "expected_benefits": ["Accelerated drug discovery", "Personalized medicine leadership", "New revenue streams", "Scientific reputation enhancement"],
    "projected_revenue": "$2 billion in new product revenue over 10 years",
    "risk_factors": ["Technology development delays", "Regulatory hurdles", "Data privacy concerns", "Market adoption challenges"]
  }
}
